Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells (Q38314884)

2 September 2017

title

Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells (English)

1 reference

2 September 2017

1 reference

Tsihlias J

1

1 reference

2 September 2017

Zhang W

2

1 reference

2 September 2017

Bhattacharya N

3

1 reference

2 September 2017

Flanagan M

4

1 reference

2 September 2017

Klotz L

5

1 reference

2 September 2017

Slingerland J

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

2 September 2017

1 reference

2 September 2017

volume

19

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

670-679

1 reference

Cyclin D1 as a cellular proto-oncogene

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Management of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

The E2F transcription factor is a cellular target for the RB protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Androgen-receptor gene structure and function in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Translational control of p27Kip1 accumulation during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

A cell cycle-regulated inhibitor of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

STUDIES ON PROSTATIC CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

D-type cyclin-dependent kinase activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Creative blocks: cell-cycle checkpoints and feedback controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Linkage of replication to start by the Cdk inhibitor Sic1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Activation of the various cyclin/cdc2 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

The cyclin-dependent kinase inhibitor p40SIC1 imposes the requirement for Cln G1 cyclin function at Start

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Association of human cyclin E with a periodic G1-S phase protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

p27 expression and gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

G1 control in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203369

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203369

1 reference

Dimensions Publication ID

2 September 2017

1042688161

0 references

1 reference